Shogo Sesoko

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects

Akiko Sarashina, Kazuki Koiwai, Leo Seman et al. · Drug Metabolism and Pharmacokinetics · 2012 · 84 citations

Family History of Hypertension and Blood Pressure in a Screened Cohort.

Masahiko Tozawa, Saori Oshiro, Chiho Iseki et al. · Hypertension Research · 2001 · 68 citations · Full text

Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects

Akiko Sarashina, Shogo Sesoko, Mitsuyoshi Nakashima et al. · Clinical Therapeutics · 2010 · 58 citations

Diabetes Management, Medicine, Diabetes +6

Brain angiotensin II contributes to the development of hypertension in Dahl-Iwai salt-sensitive rats

Hiroshi Teruya, Hiromi Muratani, Shuichi Takishita et al. · Journal of Hypertension · 1995 · 48 citations

Determination of creatinine-related molecules in saliva by reversed-phase liquid chromatography with tandem mass spectrometry and the evaluation of hemodialysis in chronic kidney disease patients

Mayu Suzuki, Mitsuyoshi Furuhashi, Shogo Sesoko et al. · Analytica Chimica Acta · 2016 · 40 citations

Reversed-phase Liquid Chromatography, Dialysis Therapy, Creatinine-related Molecules +16